Mark S. Smeltzer mostly deals with Microbiology, Staphylococcus aureus, Biofilm, Mutant and Virulence. He works in the field of Microbiology, focusing on Micrococcaceae in particular. His Micrococcaceae research includes themes of Staphylococcal infections, Staphylococcus and Polymerase chain reaction.
His work deals with themes such as Antibiotics, Pathogenesis, Pathology, Cytoskeleton and Actin, which intersect with Staphylococcus aureus. His research integrates issues of Arginine transport, Arginine, Arginine deiminase and Intrinsic resistance in his study of Biofilm. His study in Mutant is interdisciplinary in nature, drawing from both Mutation, Lysis and Gene expression.
Mark S. Smeltzer mainly investigates Microbiology, Staphylococcus aureus, Biofilm, Mutant and Virulence. His Microbiology research is multidisciplinary, relying on both Proteases, Vancomycin, Protease and Mutation. His studies deal with areas such as Extracellular, In vivo, Osteomyelitis and Pathogenesis as well as Staphylococcus aureus.
His biological study spans a wide range of topics, including In vitro and Staphylococcus epidermidis. His Mutant research incorporates elements of Phenotype, Plasmid and Regulation of gene expression. His Virulence research integrates issues from Pathogen and Operon.
The scientist’s investigation covers issues in Staphylococcus aureus, Microbiology, Biofilm, Antibiotics and Vancomycin. His work carried out in the field of Staphylococcus aureus brings together such families of science as Proteases, Protease, Osteomyelitis, In vivo and Virulence. He interconnects Extracellular and Mutant in the investigation of issues within Proteases.
His Mutant study combines topics from a wide range of disciplines, such as Mutation and Phenotype. Mark S. Smeltzer studies Microbiology, namely Amikacin. Many of his research projects under Biofilm are closely connected to Clinical Practice, Cost of care, Joint infections and Musculoskeletal infection with Clinical Practice, Cost of care, Joint infections and Musculoskeletal infection, tying the diverse disciplines of science together.
His primary scientific interests are in Antibiotics, Biofilm, Staphylococcus aureus, Microbiology and Pseudomonas aeruginosa. Mark S. Smeltzer has included themes like Benzoic acid, Vancomycin and Bacillus subtilis in his Antibiotics study. His Biofilm study incorporates themes from Extracellular, Protease, Mutation and Proteases.
He combines subjects such as Hemolysis, Rifampicin, Antimicrobial, Mutant and Virulence with his study of Staphylococcus aureus. His Microbiology study frequently draws parallels with other fields, such as Acinetobacter baumannii. His work is dedicated to discovering how Pseudomonas aeruginosa, In vivo are connected with Ciprofloxacin, Escherichia coli, Osteomyelitis, Surgical Sponges and Amikacin and other disciplines.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Global Gene Expression in Staphylococcus aureus Biofilms
Karen E. Beenken;Paul M. Dunman;Fionnuala McAleese;Daphne Macapagal.
Journal of Bacteriology (2004)
The cidA murein hydrolase regulator contributes to DNA release and biofilm development in Staphylococcus aureus.
Kelly C. Rice;Ethan E. Mann;Jennifer L. Endres;Elizabeth C. Weiss.
Proceedings of the National Academy of Sciences of the United States of America (2007)
Photothermal Nanotherapeutics and Nanodiagnostics for Selective Killing of Bacteria Targeted with Gold Nanoparticles
Vladimir P. Zharov;Kelly E. Mercer;Elena N. Galitovskaya;Mark S. Smeltzer.
Biophysical Journal (2006)
Modulation of eDNA release and degradation affects Staphylococcus aureus biofilm maturation.
Ethan E. Mann;Kelly C. Rice;Blaise R. Boles;Jennifer L. Endres.
PLOS ONE (2009)
Role of the accessory gene regulator (agr) in pathogenesis of staphylococcal osteomyelitis.
A. F. Gillaspy;S. G. Hickmon;R. A.F Skinner;J. R. Thomas.
Infection and Immunity (1995)
Mutation of sarA in Staphylococcus aureus limits biofilm formation.
Karen E. Beenken;Jon S. Blevins;Mark S. Smeltzer.
Infection and Immunity (2003)
Multiplex PCR Protocol for the Diagnosis of Staphylococcal Infection
William J. Mason;Jon S. Blevins;Karen Beenken;Noroyono Wibowo.
Journal of Clinical Microbiology (2001)
Nuclease Modulates Biofilm Formation in Community-Associated Methicillin-Resistant Staphylococcus aureus
Megan R. Kiedrowski;Jeffrey S. Kavanaugh;Cheryl L. Malone;Joe M. Mootz.
PLOS ONE (2011)
Characterization of a rabbit model of staphylococcal osteomyelitis
Mark S. Smeltzer;J. Roby Thomas;Sandra G. Hickraon;Robert A. Skinner.
Journal of Orthopaedic Research (1997)
Staphylococcus aureus AgrA Binding to the RNAIII-agr Regulatory Region
Robbin L. Koenig;Jessica L. Ray;Soheila J. Maleki;Mark S. Smeltzer.
Journal of Bacteriology (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: